{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:22:29Z","timestamp":1778275349066,"version":"3.51.4"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Isotretinoin is a vitamin A derivative widely used for moderate-to-severe acne, and is known to cause multiple systemic and ocular adverse events. Refractive errors, such as myopia and astigmatism, are commonly considered reversible after discontinuation of isotretinoin treatment. However, the visual changes and subsequent prognosis after re-exposure to isotretinoin are rarely reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Presentation<\/jats:title>\n                    <jats:p>A 21-year-old male initiated oral isotretinoin at 10\u00a0mg twice daily for acne vulgaris. Twelve days later, the patient developed acute visual deterioration. The eye examination revealed mild myopic astigmatism in the right eye and mild myopia in the left eye. The patient\u2019s visual acuity returned to normal at approximately 20 days after isotretinoin cessation. Then, the patient later self-restarted isotretinoin (10\u00a0mg, twice daily) for 10 days, which again resulted in decreased visual acuity. Although the patient discontinued isotretinoin, the visual acuity did not recover to baseline over a 14-month follow-up period. The Naranjo Adverse Drug Reaction Probability Scale was eight points, indicating a \u201cprobable\u201d causal relationship between isotretinoin and refractive error.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Myopia and astigmatism might happen concurrently after isotretinoin administration. In addition, recurrent and persistent refractive errors might occur upon restarting isotretinoin in patients with prior history of isotretinoin-related ocular complications. Clinicians should consult patients to take extra precautions on isotretinoin medication when they have a history of ocular disease or ocular complications with isotretinoin administration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1772498","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:23:44Z","timestamp":1775107424000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrent and persistent refractive errors after restarting isotretinoin treatment: a case report"],"prefix":"10.3389","volume":"17","author":[{"given":"Ming-xing","family":"Gong","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Chongqing Red Cross Hospital","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-shan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Chongqing Sanbo Changan Hospital","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Chongqing Red Cross Hospital","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Chongqing Red Cross Hospital","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s12967-025-06577-1","article-title":"In vivo confocal microscopy provides evidence of corneal nerve damage and basal tear film reduction in patients treated with oral isotretinoin","volume":"23","author":"Barros","year":"2025","journal-title":"J. Transl. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-vision-091718-015027","article-title":"Origins of refractive errors: environmental and genetic factors","volume":"5","author":"Harb","year":"2019","journal-title":"Annu. Review Vision Science"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1016\/j.cub.2022.09.005","article-title":"Retinoid therapy restores eye-specific cortical responses in adult mice with retinal degeneration","volume":"32","author":"Huh","year":"2022","journal-title":"Curr. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s13287-022-03053-1","article-title":"All-Trans retinoic acid modulates pigmentation, neuroretinal maturation, and corneal transparency in human multiocular organoids","volume":"13","author":"Isla-Magran\u00e9","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2213364","DOI":"10.1080\/09546634.2023.2213364","article-title":"Ocular side effects of systemic isotretinoin - a Systematic Review and summary of case reports","volume":"34","author":"Lamberg","year":"2023","journal-title":"J. Dermatol. Treat."},{"key":"B6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12967-017-1297-2","article-title":"P53: key conductor of all anti-acne therapies","volume":"15","author":"Melnik","year":"2017","journal-title":"J. Transl. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s42003-022-04323-7","article-title":"Rare variant analyses across multiethnic cohorts identify novel genes for refractive error","volume":"6","author":"Musolf","year":"2023","journal-title":"Commun. Biology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.1097\/ijg.0000000000000779","article-title":"Isotretinoin-Induced angle closure and myopic shift","volume":"26","author":"Park","year":"2017","journal-title":"J. Glaucoma"},{"key":"B9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/iovs.62.2.15","article-title":"Association between medication-taking and refractive error in a large general population-based cohort","volume":"62","author":"Patasova","year":"2021","journal-title":"Investigative Ophthalmol. Vis. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s42003-021-02185-z","article-title":"Loss of gap junction Delta-2 (Gjd2) gene orthologs leads to refractive error in zebrafish","volume":"4","author":"Quint","year":"2021","journal-title":"Commun. Biology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e16884","DOI":"10.7759\/cureus.16884","article-title":"Oral isotretinoin resulting in recurrence of Lasik-Treated myopia: a rare side effect","volume":"13","author":"Qureshi","year":"2021","journal-title":"Cureus"},{"key":"B12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.4103\/0378-6323.84083","article-title":"Sudden irreversible worsening of myopia with isotretinoin treatment","volume":"77","author":"Saraswat","year":"2011","journal-title":"Indian J. Dermatol Venereol. Leprol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3238\/arztebl.2016.0693","article-title":"Refractive errors","volume":"113","author":"Schiefer","year":"2016","journal-title":"Dtsch. Arztebl Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14740338.2025.2505530","article-title":"Unveiling the hidden ocular risks of isotretinoin: a comprehensive Faers-Based analysis","author":"Tao","year":"2025","journal-title":"Expert Opin. Drug Saf."},{"key":"B15","doi-asserted-by":"publisher","first-page":"759767","DOI":"10.3389\/fmed.2021.759767","article-title":"Refractive error and eye health: an umbrella review of meta-analyses","volume":"8","author":"Wang","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.66.7.4","article-title":"Perspectives on genetic and environmental factors in myopia, its prediction, and the future direction of research","volume":"66","author":"Williams","year":"2025","journal-title":"Investigative Ophthalmol. Vis. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/15569527.2020.1836649","article-title":"Effect of isotretinoin on myopia and axial length: a pilot Study","volume":"39","author":"Yasar","year":"2020","journal-title":"Cutan. Ocul. Toxicol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7554\/eLife.67315","article-title":"Canonical Nf-\u039ab signaling maintains corneal epithelial integrity and prevents corneal aging via retinoic acid","volume":"10","author":"Yu","year":"2021","journal-title":"Elife"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1772498\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:23:45Z","timestamp":1775107425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1772498\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":18,"alternative-id":["10.3389\/fphar.2026.1772498"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1772498","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"article-number":"1772498"}}